Correspondence 0001493152-23-042927 from Aimei Health Technology Co., Ltd. (AFJK)
Aimei Health Technology Co., Ltd.
Date: Nov. 28, 2023 · CIK: 0001979005 · Accession: 0001493152-23-042927
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272230
Letter
AIMEI HEALTH TECHNOLOGY CO., LTD
10 East 53rd Street, Suite 3001
New York, NY 10022
November 28, 2023
VIA EDGAR
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: Aimei Health Technology Co., Ltd(the “Company”)
Registration Statement on Form S-1
(File No. 333-272230) (the “Registration Statement”)
Ladies and Gentlemen:
The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 pm., Eastern Time, on November 30, 2023, or as soon thereafter as practicable.
The Company hereby acknowledges that:
● Should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
● The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
● The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[Signature page follows]
Very truly yours,
Aimei Health Technology Co., Ltd
Show Raw Text
CORRESP
1
filename1.htm
AIMEI
HEALTH TECHNOLOGY CO., LTD
10 East 53rd Street, Suite 3001
New York, NY 10022
November
28, 2023
VIA
EDGAR
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: Aimei
Health Technology Co., Ltd(the “Company”)
Registration Statement on Form S-1
(File No. 333-272230) (the “Registration Statement”)
Ladies
and Gentlemen:
The
Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness
of the Registration Statement so that such Registration Statement will become effective as of 4:00 pm., Eastern Time, on November 30,
2023, or as soon thereafter as practicable.
The
Company hereby acknowledges that:
● Should
the Securities and Exchange Commission (the “Commission”) or the Staff, acting
pursuant to delegated authority, declare the Registration Statement effective, it does not
foreclose the Commission from taking any action with respect to the Registration Statement;
● The
action of the Commission or the Staff, acting pursuant to delegated authority, in declaring
the Registration Statement effective, does not relieve the Company from its full responsibility
for the adequacy and accuracy of the disclosure in the Registration Statement; and
● The
Company may not assert Staff comments and the declaration of effectiveness as a defense in
any proceeding initiated by the Commission or any person under the federal securities laws
of the United States.
[Signature
page follows]
Very truly yours,
Aimei Health Technology Co., Ltd
By:
/s/
Juan Fernandez Pascual
Name:
Juan Fernandez Pascual
Title:
Chief Executive Officer